Profil
Dr. Amama Sadiq, MD, is a Senior VP-Global Medical & Scientific Affairs at Karyopharm Therapeutics, Inc. Dr. Sadiq was previously employed as a Head-North America Medical Affairs, Rare Diseases by Ipsen, Inc. and an Executive Medical Director-Womens Health by AMAG Pharmaceuticals, Inc. She received her graduate degree from Harvard T.H.
Chan School of Public Health.
Aktive Positionen von Amama Sadiq
| Unternehmen | Position | Beginn |
|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2023 |
Ehemalige bekannte Positionen von Amama Sadiq
| Unternehmen | Position | Ende |
|---|---|---|
Ipsen, Inc.
Ipsen, Inc. Industrial MachineryProducer Manufacturing Manufactures thermal processing equipment and systems | Corporate Officer/Principal | 01.05.2023 |
| AMAG PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Ausbildung von Amama Sadiq
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Ipsen, Inc.
Ipsen, Inc. Industrial MachineryProducer Manufacturing Manufactures thermal processing equipment and systems | Producer Manufacturing |
Karyopharm Therapeutics, Inc.
Karyopharm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation | Health Technology |
Harvard T.H. Chan School of Public Health
Harvard T.H. Chan School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















